학술논문

Patient-reported outcomes from the phase III IMpassion130 trial of atezolizumab plus nab-paclitaxel in metastatic triple-negative breast cancer
Document Type
Article
Source
In Annals of Oncology May 2020 31(5):582-589
Subject
Breast tumor
Language
ISSN
0923-7534